Billionaires Warren Buffett and Bill Ackman couldn’t be further apart on Valeant Pharmaceuticals International Inc.
In back-to-back television interviews Monday on CNBC, Buffett lambasted the embattled drugmaker over its price increases and business practices, while Ackman -- whose firm Pershing Square Capital Management LP is one of Valeant’s biggest holders -- praised its great products.
Read Full Article »